Equities

Iteos Therapeutics Inc

ITOS:NMQ

Iteos Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)9.19
  • Today's Change-0.19 / -2.03%
  • Shares traded370.53k
  • 1 Year change-3.87%
  • Beta1.4078
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue13268345
OPERATING EXPENSES
Cost of revenue total------
Selling, general and admin. expenses, total504441
Depreciation/amortization------
Unusual expense(income)------
Other operating expenses, total------
Total operating expense164141100
Operating income(151)126245
Other, net101112
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(109)149256
Provision for income taxes3.615242
Net income after taxes(113)97215
Minority interest------
Net income before extra. Items(113)97215
Total extraordinary items------
Net income(113)97215
Inc.avail. to common excl. extra. Items(113)97215
Inc.avail. to common incl. extra. Items(113)97215
EPS RECONCILIATION
Basic/primary weighted average shares363635
Basic/primary eps excl. extra items(3.15)2.726.10
Basic/primary eps incl. extra items(3.15)2.726.10
Dilution adjustment------
Diluted weighted average shares363838
Diluted eps excl. extra items(3.15)2.565.68
Diluted eps incl. extra items(3.15)2.565.68
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental------
SUPPLEMENTAL INCOME
Depreciation, supplemental0.900.800.60
Total special items------
NORMALISED INCOME
Normalized income before taxes(109)149256
Effect of special items on income taxes------
Income tax excluding impact of special items3.615242
Normalized income after tax(113)97215
Normalized income avail. to common(113)97215
Basic normalized EPS(3.15)2.726.10
Diluted normalized EPS(3.15)2.565.68
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.